ABBOTT LABORATORIES — Director's Dealing 2020

Mar 9, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2020-03-01

Reporting Person: Boudreau Philip P (Vice President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	33063	Direct
Common shares without par value	330	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (right to buy)	$87.72	2030-02-20	Common shares (29020)		Direct

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of March 5, 2020.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,673 on February 21, 2021, 9,673 on February 21, 2022, and 9,674 on February 21, 2023.